On track to submit GraftAssureDx™ for FDA review by year-endOn track for commitment to have 20 transplant centers globally ...

WALTHAM, Mass. and BOULDER, Colo., Nov. 10, 2025 (GLOBE NEWSWIRE) -- (“Cogent”) (Nasdaq: COGT), a biotechnology company focused on developing precision therapies for genetically defined diseases, tod ...

The Q3 2025 dividend will be paid on December 15, 2025 to shareholders of record at the close of business on November 28, 2025.

J.P. Morgan, Jefferies, Leerink Partners and Guggenheim Securities are acting as joint-book running managers for the proposed Equity Offering. LifeSci Capital is acting as lead manager and Raymond ...

AZB & Partners has dominated M&A deals in the financial services space while CAM, SAM, Trilegal and JSA fight for market ...